共 8 条
[1]
Delayed development of ventricular ectopic rhythm following experimental coronary occlusion. Hamis A S. Circulation . 1950
[2]
Effects of MS-551, a new class Ⅲ antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, eledrophysiology, and hemodynamics in a canine myocardial infarction model. Kondoh K,Hashimoto H,Nishiyama H,et al. Journal of Cardiovascular Pharmacology . 1994
[3]
Antiarrhythmic effects of MS-551, a new class Ⅲ antiarrhythmic agent, on canine models of ventricular arrhythmia. Kamiya J,Ishii M,KataKami T. Japanese Journal of Pharmacology . 1992
[4]
Synthesis and pharmacological studies of N-substituted 6-[( 2aminoethyl) amino] 1, 3-dimethyl 2, 4 ( 1H, 3H)-pyrimidinediones, novel class Ⅲ antiarrhythmic agents. Katakami T,Yokoyama T,Miyamoto M,et al. Medicinal Chemistry . 1992
[5]
Participationof (1a drenoceptersintheproarrhythmiceffectofclassⅢantiar rhythmicagentsinhalothaneanesthtizeddogs. SugaH,SatohT,IshiiM,etal. Japanese Journal of Pharmacology . 1992
[6]
A new class Ⅲ antiarrhythmic drug, MS-551 , blocks the inward rectifier potassium channel in isolated guinea pig ventricular myocytes. Sato R,Koumi S,Hisatome I,et al. Journal of Pharmacology and Experimental Therapeutics . 1995
[7]
Antiarrhythmic effect and hemodynamic properties of MS-551, a new classⅢantiarrhythmic agent, in anaesthetized dogs. Kayami J,Banno H,Yoshihara K,et al. European Journal of Pharmacology . 1980
[8]
MS-551: Pharmacological profile of a novel class Ⅲ antiarrhythmic agent. Kamiya J,Ishii M,Yoshihara K,et al. Drug Development Research . 1993